Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven ...

Optomap green-channel lesion intensity correlates with ultrasonographic choroidal tumor thickness, according to research.

The fireside chat will be webcasted and available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be ...

Principal Financial Group Inc. decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 6.7% in the fourth quarter, according to the company in its most recent ...

Dermatology Nursing. 2005;17(3):188-190. A 45-year-old woman presented with a rapidly changing nevus on her leg. The clinical approach, epidemiology, diagnostic procedures, and management, along ...

New in vivo evidence confirms that tumor-expressed Fas ligand impairs immune responses to cancer by inducing apoptosis of anti-tumor immune effector cells. A recent report demonstrated that murine ...

Men undergo screening for skin cancer at lower rates than women, but they’re at higher lifetime risk for some types of skin cancer, like melanoma. Screening is key for early detection and ...

Background: The combination therapy of BRAF inhibitors (BRAFis) and MEK inhibitors (MEKis) has been approved as a first-line treatment for metastatic melanoma with BRAF V600 mutants. Recently, BRAF ...